37th Australasian Dermatopathology Society

 

ANNUAL SCIENTIFIC MEETING

auckland 9 - 11 September 2016

 


THANK YOU FOR ATTENDING ADS 2016

On behalf of the Organising Committee we would like to thank you for joining us in Auckland for the 37th Australasian Dermatopathology Society Annual Scientific Meeting 2016. 

We hope you found the Meeting delivered an exciting, motivating and stimulating program and provided the opportunity to network with colleagues.

We look forward to welcoming you to Melbourne, Australia in August 2017.

Keynote Speakers

We are excited to announce the following Keynote Speakers will be presenting at the Meeting:

  Dr Jeffrey North and Dr Andrew Carlson          

 

Dr Jeffrey North and Dr Andrew Carlson          

Dr Jeffrey North

Assistant Professor of Dermatology and Pathology | University of California, San Francisco

Jeff North, MD is an assistant Professor of dermatology and pathology at the University of California San Francisco. After finishing undergraduate studies in molecular biology and chemistry at Brigham Young University, he attended medical school at UCSF and began working on melanoma genetics with Boris Bastian, M.D.
This research continued during his dermatology residency at Oregon Health & Science University, and involved characterization of a field effect in acral melanoma and demonstrating a prognostic difference in melanomas possessing certain chromosomal aberrations. He returned to UCSF for Dermatopathology fellowship, after which he started the dermatopathology service at the University of Missouri as the director of dermatopathology. In 2013 he rejoined the faculty at UCSF focusing on dermatopathology and molecular testing and attending in the dermatology clinic as well.

His interests include increasing diagnostic precision in both inflammatory and neoplastic dermatologic conditions. This includes utilizing molecular techniques such as fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH) and deep sequencing techniques to better characterize melanocytic tumors and provide better prognostic information for patients based on cancer-related changes in the tumor genome. He is also interested in immunoprofiling inflammatory skin diseases to allow for more precise diagnosis and understanding of these diseases. He serves as an associate editor for the Journal of Cutaneous Pathology and has published numerous articles and book chapters on a broad range of issues in dermatopathology. 

 

Dr Andrew Carlson

Professor of Pathology |  Albany Medical College

J.Andrew Carlson, MD, FRCP(C) is Professor of Dermatology and Pathology in the department of Pathology at Albany Medical College, Albany, NY. His research interests include melanoma, vasculitis, lymphedema, lichen sclerosus, and HPV infection. After graduation from medical school at McGill University, Montreal, QC Canada in 1988; he did an Internship at St. Joseph's Health Center, Toronto, Ontario, Canada; an anatomic pathology residency at Massachusetts General Hospital, Boston, Massachusetts; and a dermatopathology fellowship at the University of California at San Francisco, California. Since his fellowship, he has practiced dermatopathology and performed research at Albany Medical College, Albany New York, for over 22 years, where he has been Chief of the Dermatopathology service since 1996. Currently, he is the President of the International Society of Dermapathology (2013 - 2016), whose aim is to increase dermatopathology knowledge and promote friendship and scientific exchanges among members of different countries. His body of work consists of over 200 publications including original research, case series/reports, book chapters and review articles where correlations between basic research and histopathologic findings are sought, assisted by collaborations with basic science researchers.

 

Abstract Submissions now closed

Two categories of submission

Abstract authors were requested to submit their abstract under one of the following two categories for inclusion in the ADS 2016 program.

1. Brenan Prize

Accredited registrars in Dermatology or Pathology were encouraged to present a paper related to dermatopathology at the ADS 2016 Meeting. Eligible persons to enter and win the Brenan Prize included trainees in Dermatology or Pathology who were accredited for their training as specialist dermatologists or pathologists in Australia or New Zealand.

  • Abstracts should be no longer than 300 words.
  • Presentations will be up to 10 minutes depending on the number of entrants. The timing for presentations will be advised well before the presentation.
  • The paper judged to be the most meritorious and/or best presented will receive a prize of AU$1,000.  To be eligible for the prize the registrar must present in person.

2. Clinicopathological Gems

All registrants were invited to participate in this popular segment, giving a short presentation on an illustrative case or cases they have encountered.

  • Abstracts should be no longer than 150 words.
  • Presentations must be no longer than 5 minutes.
  • Multiple presentations may be accepted.

General Policies and Requirements

  • All abstracts must be original work.
  • Submission acknowledges consent to publication of the abstract in the Meeting handbook.
  • The presenting author will be required to register for the Meeting in order to ensure their abstract(s) is included in the final program. Deadline for presenting author registration is Friday 22 July 2016.
  • It is essential that authors obtain written permission to reproduce material from other sources and acknowledge those sources. Agreement must be obtained from all co-authors or parties relevant to the case and, if necessary, patient consent must be obtained.

Notification of Acceptance

Abstracts are being reviewed by the Organising Committee and notifications of acceptance will be sent via email to the submitting author by Monday 11 July 2016. 

Join our mailing list

JOIN OUR MAILING LIST to be kept up to date with information on the 37th Australasian Dermatopathology Society Annual Meeting. 


EXHIBITOR

Ego Pharmaceuticals will be returning to this year's Meeting.  Please visit the team onsite in the Foyer for further information on what they have to offer.